Sexual Health Moderate Evidence
PT-141
Bremelanotide
1 min read
Regulatory Status
🇺🇸 United States
Prescription Only Bremelanotide has an FDA-approved branded form, while compounded sourcing remains a separate regulatory question.
FDA · Updated Apr 2026
🇬🇧 United Kingdom
Restricted Availability depends on local prescribing and import rules.
MHRA · Updated Apr 2026
🇦🇺 Australia
Restricted Typically treated as prescription-only where available.
TGA · Updated Apr 2026
🏅 WADA
Not Assessed Not specifically listed in current WADA materials reviewed for this profile.
WADA · Updated Apr 2026
Overview
PT-141 is unusual in this group because bremelanotide has an FDA-approved drug form. That does not automatically resolve the broader questions around compounded peptide sourcing or off-label commercial positioning, which is why it still shows up in reclassification conversations.